MyJournals Home  

RSS FeedsModelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model (BMC Nephrology)

 
 

23 april 2019 19:01:15

 
Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model (BMC Nephrology)
 


The short-term efficacy of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) has been demonstrated across several phase 3 trials, while the ADPKD Outcomes Model (ADPKD-OM) represe...


 
71 viewsCategory: Pathology
 
Anti-fibrotic effect of mycophenolate mofetil on Peyronie`s disease experimentally induced with TGF-? (International Journal of Impotence Research)
Reliability of a new loaded rolling wheel system for measuring spinal stiffness in asymptomatic participants (BMC Musculoskeletal Disorders)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten